BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 15, 2010
 |  BC Week In Review  |  Company News  |  Deals

Pharmaxis, Topigen deal

Pharmaxis completed its previously announced acquisition of Topigen in a stock deal valued at A$8.1 million (US$7 million),...

Read the full 69 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >